Outcome of SARS-CoV-2 Infection in Patients with Rheumatoid Arthritis Under Treatment with Janus Kinase Inhibitors Compared to Tumour Necrosis Factor Inhibitors - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Outcome of SARS-CoV-2 Infection in Patients with Rheumatoid Arthritis Under Treatment with Janus Kinase Inhibitors Compared to Tumour Necrosis Factor Inhibitors

Authors list: Hasseli, Rebecca; Hoyer, Bimba Franziska; Lorenz, Hanns-Martin; Pfeil, Alexander; Regierer, Anne; Richter, Jutta; Schmeiser, Tim; Strangfeld, Anja; Voll, Reinhard; Krause, Andreas; Schulze-Koops, Hendrik; Specker, Christof; Mueller-Ladner, Ulf

Publication year: 2021

Pages: 187-189

Journal: Arthritis & Rheumatology

Volume number: 73

ISSN: 2326-5191

eISSN: 2326-5205

Conference: ACR Convergence Conference

Publisher: Wiley

Citation Styles

Harvard Citation style: Hasseli, R., Hoyer, B., Lorenz, H., Pfeil, A., Regierer, A., Richter, J., et al. (2021) Outcome of SARS-CoV-2 Infection in Patients with Rheumatoid Arthritis Under Treatment with Janus Kinase Inhibitors Compared to Tumour Necrosis Factor Inhibitors, Arthritis & Rheumatology, 73, pp. 187-189

APA Citation style: Hasseli, R., Hoyer, B., Lorenz, H., Pfeil, A., Regierer, A., Richter, J., Schmeiser, T., Strangfeld, A., Voll, R., Krause, A., Schulze-Koops, H., Specker, C., & Mueller-Ladner, U. (2021). Outcome of SARS-CoV-2 Infection in Patients with Rheumatoid Arthritis Under Treatment with Janus Kinase Inhibitors Compared to Tumour Necrosis Factor Inhibitors. Arthritis & Rheumatology. 73, 187-189.